Reproducibility of Interferon Gamma (IFN-γ) Release Assays. A Systematic Review

• Published in: Annals of the American Thoracic Society Vol. 11; no. 8; pp. 1267 - 1276
• Main Authors: Tagmouti, Saloua, Slater, Madeline, Benedetti, Andrea, Kik, Sandra V., Banaei, Niaz, Cattamanchi, Adithya, Metcalfe, John, Dowdy, David, van Zyl Smit, Richard, Dendukuri, Nandini, Pai, Madhukar, Denkinger, Claudia
• Format: Journal Article
• Language: English
• Published: United States American Thoracic Society 01.10.2014
• Subjects: Humans; Interferon-gamma - blood; Interferon-gamma - immunology; Reproducibility of Results; Systematic Review; Tuberculin - immunology; Tuberculosis - blood; Tuberculosis - diagnosis; Tuberculosis - immunology; diagnostics; reproducibility; IFN-γ release assays; tuberculosis
• ISSN: 2329-6933; 2325-6621; 2325-6621
• DOI: 10.1513/AnnalsATS.201405-188OC

Interferon gamma (IFN-γ) release assays for latent tuberculosis infection result in a larger-than-expected number of conversions and reversions in occupational screening programs, and reproducibility of test results is a concern. Knowledge of the relative contribution and extent of the individual sources of variability (immunological, preanalytical, or analytical) could help optimize testing protocols. We performed a systematic review of studies published by October 2013 on all potential sources of variability of commercial IFN-γ release assays (QuantiFERON-TB Gold In-Tube and T-SPOT.TB). The included studies assessed test variability under identical conditions and under different conditions (the latter both overall and stratified by individual sources of variability). Linear mixed effects models were used to estimate within-subject SD. We identified a total of 26 articles, including 7 studies analyzing variability under the same conditions, 10 studies analyzing variability with repeat testing over time under different conditions, and 19 studies reporting individual sources of variability. Most data were on QuantiFERON (only three studies on T-SPOT.TB). A considerable number of conversions and reversions were seen around the manufacturer-recommended cut-point. The estimated range of variability of IFN-γ response in QuantiFERON under identical conditions was ±0.47 IU/ml (coefficient of variation, 13%) and ±0.26 IU/ml (30%) for individuals with an initial IFN-γ response in the borderline range (0.25-0.80 IU/ml). The estimated range of variability in noncontrolled settings was substantially larger (±1.4 IU/ml; 60%). Blood volume inoculated into QuantiFERON tubes and preanalytic delay were identified as key sources of variability. This systematic review shows substantial variability with repeat IFN-γ release assays testing even under identical conditions, suggesting that reversions and conversions around the existing cut-point should be interpreted with caution.